VB-111 will succeed to pass all primary and secondary endpoints. The market assume VB-111 will fail but the market assumption is only by using statistic based on past results. People here are surprised how come doctors are not investing....I gave in past many examples of wrong doing in this field of immunotherapy and lack of scientific world understanding. Doctors know that many immunotherapy drugs failed in rgbm and they also assume vb111 will fail like Optivo failed and so on. Even if they hear from their friends doctor that vb111 is a great success they will still think it's going to fail. When we as humans brain washed we don't know we are . Here is a case that fear together with brain washed plus the fact the company has zero attention and some other factors cause this predicting of failure in stock price. The market predicted 3 ph2 failures as well otherwise the spikes were not so prominent when it passed.
Market Data 
Markets 
AI
